Neo Performance Materials (NEO) Q4 2024 earnings summary

Executive summary

• Adjusted EBITDA grew over 70% year-over-year to $64.4M in 2024, exceeding guidance, driven by Rare Metals and Magnequench segments.

• Major capital projects completed, including Emissions Control Catalyst facility under budget and European Permanent Magnet facility on track for 2025 opening.

• Portfolio streamlined with divestment of non-core assets, including rare earth separation facilities in China and Gallium Trichloride facility in Oklahoma.

• Maintained strong balance sheet with $85M in cash and net cash position at year-end.

• Strategic review process ongoing to optimize business and maximize shareholder value.

Financial highlights

• FY2024 revenue was $475.8M, down from $571.5M in 2023; Q4 2024 revenue was $134.9M.

• FY2024 Adjusted EBITDA was $64.4M; Q4 2024 Adjusted EBITDA was $20.7M.

• Adjusted net income for 2024 was $1.98M ($0.05/share); Q4 2024 Adjusted net loss was ($4.89M), Adjusted EPS ($0.12).

• Generated $51.5M in cash from operations in 2024; ended year with $85.5M in cash.

• Returned $12.3M to shareholders via dividends and $2.3M in share buybacks in 2024.

Outlook and guidance

• 2025 Adjusted EBITDA guidance raised to $55–$60M, up from previous $53–$58M.

• Commercial production at European Permanent Magnet facility expected in 2026; customer qualification sample production to begin in 2025.

• Sale of Chinese separation facilities expected to close in H1 2025, generating ~$30M in cash.

• Focus on self-funding growth, operational efficiency, and cost reductions, with sustaining CapEx of $4–8M per year.

• Strategic targets include 10% annual SG&A reduction for three years and >10% growth in specialty oxides.